Royalty Pharma plc (RPRX) Shareholders’ equity 2018–2025
Royalty Pharma plc (RPRX) shareholders’ equity at each fiscal year-end, per SEC filings.
$9.7BFY2025 · since FY2018: $4.6B → $9.7B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $9.7B | -6.1% |
| FY2024 | $10.3B | +2.6% |
| FY2023 | $10.1B | +5.9% |
| FY2022 | $9.5B | -7.1% |
| FY2021 | $10.2B | +3.6% |
| FY2020 | $9.9B | +61.1% |
| FY2019 | $6.1B | +34.9% |
| FY2018 | $4.6B | — |
Source: SEC XBRL filings · For reference only · Not investment advice